130 related articles for article (PubMed ID: 15254882)
1. Free fatty acids increase hepatic glycogen content in obese males.
Allick G; Sprangers F; Weverling GJ; Ackermans MT; Meijer AJ; Romijn JA; Endert E; Bisschop PH; Sauerwein HP
Metabolism; 2004 Jul; 53(7):886-93. PubMed ID: 15254882
[TBL] [Abstract][Full Text] [Related]
2. Effect of decreasing plasma free fatty acids by acipimox on hepatic glucose metabolism in normal rats.
Lee KU; Park JY; Kim CH; Hong SK; Suh KI; Park KS; Park SW
Metabolism; 1996 Nov; 45(11):1408-14. PubMed ID: 8931647
[TBL] [Abstract][Full Text] [Related]
3. Restoration of growth hormone (GH) response to GH-releasing hormone in elderly and obese subjects by acute pharmacological reduction of plasma free fatty acids.
Pontiroli AE; Manzoni MF; Malighetti ME; Lanzi R
J Clin Endocrinol Metab; 1996 Nov; 81(11):3998-4001. PubMed ID: 8923850
[TBL] [Abstract][Full Text] [Related]
4. Chronic reduction of plasma free fatty acid improves mitochondrial function and whole-body insulin sensitivity in obese and type 2 diabetic individuals.
Daniele G; Eldor R; Merovci A; Clarke GD; Xiong J; Tripathy D; Taranova A; Abdul-Ghani M; DeFronzo RA
Diabetes; 2014 Aug; 63(8):2812-20. PubMed ID: 24353180
[TBL] [Abstract][Full Text] [Related]
5. Impaired growth hormone secretion in obese subjects is partially reversed by acipimox-mediated plasma free fatty acid depression.
Cordido F; Peino R; Peñalva A; Alvarez CV; Casanueva FF; Dieguez C
J Clin Endocrinol Metab; 1996 Mar; 81(3):914-8. PubMed ID: 8772550
[TBL] [Abstract][Full Text] [Related]
6. Hepatic gluconeogenic fluxes and glycogen turnover during fasting in humans. A stable isotope study.
Hellerstein MK; Neese RA; Linfoot P; Christiansen M; Turner S; Letscher A
J Clin Invest; 1997 Sep; 100(5):1305-19. PubMed ID: 9276749
[TBL] [Abstract][Full Text] [Related]
7. Effect of a sustained reduction in plasma free fatty acid concentration on insulin signalling and inflammation in skeletal muscle from human subjects.
Liang H; Tantiwong P; Sriwijitkamol A; Shanmugasundaram K; Mohan S; Espinoza S; Defronzo RA; Dubé JJ; Musi N
J Physiol; 2013 Jun; 591(11):2897-909. PubMed ID: 23529132
[TBL] [Abstract][Full Text] [Related]
8. Effect of acute pharmacological reduction of plasma free fatty acids on growth hormone (GH) releasing hormone-induced GH secretion in obese adults with and without hypopituitarism.
Cordido F; Fernandez T; Martinez T; Peñalva A; Peinó R; Casanueva FF; Dieguez C
J Clin Endocrinol Metab; 1998 Dec; 83(12):4350-4. PubMed ID: 9851776
[TBL] [Abstract][Full Text] [Related]
9. FFAs are not involved in regulation of gluconeogenesis and glycogenolysis in adults with uncomplicated P. falciparum malaria.
van Thien H; Weverling GJ; Ackermans MT; canh Hung N; Endert E; Kager PA; Sauerwein HP
Am J Physiol Endocrinol Metab; 2004 Oct; 287(4):E609-15. PubMed ID: 15165991
[TBL] [Abstract][Full Text] [Related]
10. Effects on insulin secretion and insulin action of a 48-h reduction of plasma free fatty acids with acipimox in nondiabetic subjects genetically predisposed to type 2 diabetes.
Cusi K; Kashyap S; Gastaldelli A; Bajaj M; Cersosimo E
Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1775-81. PubMed ID: 17299078
[TBL] [Abstract][Full Text] [Related]
11. Lowering plasma free fatty acids with Acipimox mimics the antidiabetic effects of the beta 3-adrenergic agonist CL-316243 in obese Zucker diabetic fatty rats.
Blachère JC; Pérusse F; Bukowiecki LJ
Metabolism; 2001 Aug; 50(8):945-51. PubMed ID: 11474483
[TBL] [Abstract][Full Text] [Related]
12. Effect of a sustained reduction in plasma free fatty acid concentration on intramuscular long-chain fatty Acyl-CoAs and insulin action in type 2 diabetic patients.
Bajaj M; Suraamornkul S; Romanelli A; Cline GW; Mandarino LJ; Shulman GI; DeFronzo RA
Diabetes; 2005 Nov; 54(11):3148-53. PubMed ID: 16249438
[TBL] [Abstract][Full Text] [Related]
13. Overnight lowering of free fatty acids with Acipimox improves insulin resistance and glucose tolerance in obese diabetic and nondiabetic subjects.
Santomauro AT; Boden G; Silva ME; Rocha DM; Santos RF; Ursich MJ; Strassmann PG; Wajchenberg BL
Diabetes; 1999 Sep; 48(9):1836-41. PubMed ID: 10480616
[TBL] [Abstract][Full Text] [Related]
14. Metabolic and endocrine consequences of acute suppression of FFAs by acipimox in polycystic ovary syndrome.
Ciampelli M; Muzj G; Leoni F; Romualdi D; Belosi C; Cento RM; Lanzone A
J Clin Endocrinol Metab; 2001 Nov; 86(11):5324-9. PubMed ID: 11701699
[TBL] [Abstract][Full Text] [Related]
15. Endogenous glucose production, gluconeogenesis and liver glycogen concentration in obese non-diabetic patients.
Müller C; Assimacopoulos-Jeannet F; Mosimann F; Schneiter P; Riou JP; Pachiaudi C; Felber JP; Jéquier E; Jeanrenaud B; Tappy L
Diabetologia; 1997 Apr; 40(4):463-8. PubMed ID: 9112024
[TBL] [Abstract][Full Text] [Related]
16. Effect of acute acipimox administration on the rates of lipid and glycogen synthesis in cachectic tumor-bearing rats.
Obeid OA; Emery PW
Nutr Cancer; 1997; 28(1):100-6. PubMed ID: 9200157
[TBL] [Abstract][Full Text] [Related]
17. Sustained reduction in plasma free fatty acid concentration improves insulin action without altering plasma adipocytokine levels in subjects with strong family history of type 2 diabetes.
Bajaj M; Suraamornkul S; Kashyap S; Cusi K; Mandarino L; DeFronzo RA
J Clin Endocrinol Metab; 2004 Sep; 89(9):4649-55. PubMed ID: 15356076
[TBL] [Abstract][Full Text] [Related]
18. Metabolic Effects of Long-Term Reduction in Free Fatty Acids With Acipimox in Obesity: A Randomized Trial.
Makimura H; Stanley TL; Suresh C; De Sousa-Coelho AL; Frontera WR; Syu S; Braun LR; Looby SE; Feldpausch MN; Torriani M; Lee H; Patti ME; Grinspoon SK
J Clin Endocrinol Metab; 2016 Mar; 101(3):1123-33. PubMed ID: 26691888
[TBL] [Abstract][Full Text] [Related]
19. Effects of an acute decrease in non-esterified fatty acid levels on muscle glucose utilization and forearm indirect calorimetry in lean NIDDM patients.
Piatti PM; Monti LD; Davis SN; Conti M; Brown MD; Pozza G; Alberti KG
Diabetologia; 1996 Jan; 39(1):103-12. PubMed ID: 8720610
[TBL] [Abstract][Full Text] [Related]
20. Sources of plasma glucose and liver glycogen in fasted ob/ob mice.
Turner SM; Linfoot PA; Neese RA; Hellerstein MK
Acta Diabetol; 2005 Dec; 42(4):187-93. PubMed ID: 16382307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
